Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men

European Journal of Clinical Investigation

Volumn 30, Issue 1, 2000, Pages 18-25

  Kakko, Sakari ^a   Tamminen, M ^a   Paivansalo M ^a   Kauma, H ^a   Rantala, A O ^a   Lilja, M ^a   Reunanen, A ^b   Kesaniemi Y A ^a   Savolainen, M J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Alcohol; Cholesteryl ester transfer protein; Genetic polymorphism; HDL; Intima media thickness

Indexed keywords

ALCOHOL; CHOLESTEROL ESTER TRANSFER PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ALLELES; CAROTID ARTERY DISEASES; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GENOTYPE; GLYCOPROTEINS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUNICA INTIMA;

EID: 0033956188     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00595.x     Document Type: Article

References (32)

1. 1 Kannel WB, Gordon T, Castelli WP. Role of lipids and lipoprotein fractions in atherogenesis: the Framingham Study. Prog Lipid Res 1981;20:339-48.
2. 2 Hesler CB, Swenson TL, Tall AR. Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem 1987;262:2275-82.
3. 3 Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998;18:297-330.
4. 4 Brown ML, Inazu A, Hesler CB et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989;342:448-51.
5. 5 Agellon LB, Walsh A, Hayek T et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 1991;266:10796-801.
6. 6 Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester protein. Nature 1993;364:73-5.
7. 7 Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991;87:1559-66.
8. 8 Bhatnagar D, Durrington PN, Channon KM, Prais H, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 1993;98:25-32.
9. 9 Hayek T, Masucci-Magoulas L, Jiang X et al. Decreased early atherosclerotic lesions in hypertriglyceridernic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995;96:2071-4.
10. 10 Zhong S, Sharp DS, Grove JS et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996;97:2917-23.
11. 11 Hirano K, Yamashita S, Nakajima N et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagri area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 1997;17:1053-9.
12. 12 Bruce C, Sharp DS, Tall AR. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res 1998;39:1071-8.
13. 13 Kakko S, Tamminen M, Kesäniemi YA, Savolainen MJ. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity. Atherosclerosis 1998;136:233-40.
14. 14 Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesäniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999;245:163-74.
15. 15 Hannuksela M, Marcel YL, Kesäniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992;33:737-44.
16. 16 Groener JE, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/ exchange activity in serum or plasma. Clin Chem 1986;32:283-6.
17. 17 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988;16:1215.
18. 18 Kauma H, Päivänsalo M, Savolainen MJ et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens 1996;14:1183-7.
19. 19 Wendelhag I, Gustavsson T, Suurküla M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991;11:565-77.
20. 20 Hartl DL. A primer of Population Genetics. 2nd ed. Sunderland: Sinauer Associates;1988.
21. 21 Rantala AO, Päivänsalo M, Kauma H et al. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects. Diabetes Care 1998;21:1188-93.
22. 22 Geroulakos G, O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994;15:781-5.
23. 23 O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Res Group. N Engl J Med 1999;340:14-22.
24. 24 Blankenhorn DH, Selzer RH, Crawford DW et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two-and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993;88:20-8.
25. 25 Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991;88:2059-66.
26. 26 Liinamaa MJ, Hannuksela ML, Kesäniemi YA, Savolainen MJ. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol 1997;17:2940-7.
27. 27 Kuivenhoven JA, de Knijff P, Boer JM et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997;17:560-8.
28. 28 Gudnason V, Kakko S, Nicaud V et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 1999;29:116-28.
29. 29 Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 1994;110:35-44.
30. 30 Fumeron F, Betoulle D, Luc G et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995;96:1664-71.
31. 31 Kauma H, Savolainen MJ, Heikkilä R et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 1996;97:156-62.
32. 32 Föger B, Luef G, Ritsch A et al. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J Mol Med 1995;73:369-72.